In the last week, the United States market has stayed flat, yet it is up 26% over the past year with earnings forecast to grow by 17% annually. In such a robust market environment, identifying stocks trading below their intrinsic value can present unique opportunities for investors seeking potential growth.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| Unity Software (U) |
$29.22 |
$56.46 |
48.3% |
| Robert Half (RHI) |
$29.56 |
$58.80 |
49.7% |
| Rayonier (RYN) |
$20.93 |
$40.31 |
48.1% |
| Merck (MRK) |
$114.70 |
$228.62 |
49.8% |
| Kaspi.kz (KSPI) |
$85.63 |
$166.19 |
48.5% |
| Goosehead Insurance (GSHD) |
$34.37 |
$66.13 |
48% |
| First Merchants (FRME) |
$38.90 |
$76.18 |
48.9% |
| FB Financial (FBK) |
$51.81 |
$101.61 |
49% |
| Coastal Financial (CCB) |
$67.82 |
$134.79 |
49.7% |
| AbbVie (ABBV) |
$217.13 |
$420.12 |
48.3% |
Let's review some notable picks from our screened stocks.
Mesa Laboratories
Overview:Mesa Laboratories, Inc. is a company that develops, designs, manufactures, sells, and services life sciences tools and quality control products globally with a market cap of approximately $589.29 million.
Operations:The company's revenue segments include Clinical Genomics ($45.39 million), Calibration Solutions ($53.55 million), Biopharmaceutical Development ($48.63 million), and Sterilization and Disinfection Control ($101.57 million).
Estimated Discount To Fair Value:38.2%
Mesa Laboratories is trading at US$104.38, significantly below its estimated future cash flow value of US$168.86, indicating a potential undervaluation. Despite slower revenue growth forecasts of 4.4% annually compared to the market's 12.1%, its earnings are expected to grow significantly at 30.8% per year, surpassing the broader market's 17.2%. Recent leadership changes and improved profitability further position Mesa favorably for investors focused on cash flow valuation metrics.
Silvaco Group
Overview:Silvaco Group, Inc. offers TCAD software, EDA software, and semiconductor intellectual property solutions both in the United States and internationally, with a market cap of $397.82 million.
Operations:The company generates revenue of $66.73 million from its software and programming segment, which includes technology computer aided design and electronic design automation software, as well as semiconductor intellectual property solutions.
Estimated Discount To Fair Value:16.4%
Silvaco Group is trading at US$12.68, below its estimated future cash flow value of US$15.17, suggesting potential undervaluation based on cash flows. Despite a volatile share price and less than one year of cash runway, revenue is forecast to grow faster than the US market at 12.5% annually. Recent strategic partnerships and product innovations in semiconductor technology enhance its position for future profitability within three years, aligning with above-average market growth expectations.
Betterware de MéxicoP.I. de
Overview:Betterware de México, S.A.P.I. de C.V. operates as a direct-to-consumer selling company in the United States and Mexico with a market cap of $702.05 million.
Operations:Betterware de México generates its revenue primarily through direct-to-consumer sales in the United States and Mexico.
Estimated Discount To Fair Value:42%
Betterware de México is trading at $18.54, significantly below its estimated future cash flow value of $31.95, indicating undervaluation based on cash flows. Despite a high level of debt and an unstable dividend track record, the company reported strong earnings growth with net income more than doubling year-over-year. Earnings are expected to grow at 26.3% annually, surpassing US market averages and enhancing its potential for future profitability despite recent dividend decreases.
Next Steps
-
Explore the 130 names from our Undervalued US Stocks Based On Cash Flows screener here.
-
Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
-
Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Seeking Other Investments?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MLAB SVCO and BWMX .
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
